New Delhi, Delhi
GST No. 07AAKFN5053A1ZK
Call 08048982480 88% Response Rate
Send Enquiry
Product Brochure
| Strength | 100 mg |
| Pack Size | 120 tablets |
| Brand | Bosutris |
| Composition | Bosutinib 100 mg |
| Form | Tablet |
| Packaging Type | Bottle |
| Salt Composition | Bosutinib Tablets |
| Marketer | MYLAN PHARMACEUTICALS PVT LTD |
Bosutris 100mg Tablet contains the active ingredient bosutinib. It belongs to the group of medications called Tyrosine kinase inhibitors. It is indicated to treat adult patients with a type of leukaemia known as Philadelphia chromosome-positive (Ph-positive) Chronic Myeloid Leukaemia (CML) who have been newly diagnosed or for whom earlier CML treatments have either failed or have not worked or are not suitable.
Philadelphia chromosome-positive chronic myelogenous leukaemia is a blood cancer in which the body produces too many of a specific kind of white blood cell called granulocytes.
Low white blood cell count (leukopenia), headache, shortness of breath, joint pain, dizziness, cough, back pain, decreased appetite, respiratory tract infection, raised blood pressure, ringing in the ears (tinnitus), itching, acne, dehydration, taste change, sensitivity to light and fluid on lungs are the common side effects of Bosutris 100mg Tablet. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Bosutris 100mg Tablet or its ingredients. Before taking this medication, report to your doctor if you have heart problems, bleeding problems, kidney and liver disorders, infection, or diarrhoea.
It is not recommended for children under the age of 18. Limit your time outside and use sunscreen if you must go outside, as this medicine can make you more sensitive to the sun or UV rays.
View Complete details